CANB - Can B Corp
0.038
-0.009 -23.684%
Share volume: 424,548
Last Updated: 05-05-2025
Wholesale/Wholesale – Drugs & Drug Proprietaries:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$0.05
-0.01
-0.19%
View ratios
Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
Report Date | 07-16-2024 | 08-21-2023 | 11-20-2023 | 11-19-2024 | 07-16-2024 | 08-19-2024 | 11-19-2024 | |
Total revenue | 939.305 K | 420.593 K | 418.957 K | 376.889 K | 369.096 K | 272.287 K | 15.269 K | |
Cost of revenue | 524.577 K | 934.425 K | 1.236 M | -897.602 K | 1.193 M | 665.471 K | 415.816 K | |
Gross profit | 414.728 K | -513.832 K | -816.690 K | 1.274 M | -824.065 K | -393.184 K | -400.547 K | |
-223.90% | -58.94% | 256.06% | -164.66% | 52.29% | -1.87% | |||
Operating expenses | 1.850 M | 1.308 M | 2.762 M | 0.000 | 1.688 M | 1.174 M | 2.432 M | |
Selling general and admin | 1.850 M | 1.308 M | 2.762 M | 0.000 | 1.688 M | 1.174 M | 2.432 M | |
Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Total expenses | 1.850 M | 1.308 M | 2.762 M | 1.926 M | 4.831 M | 1.174 M | 2.432 M | |
-29.30% | 111.16% | -30.25% | 150.79% | -75.70% | 107.22% | |||
Operating income | -1.435 M | -1.822 M | -3.578 M | -651.715 K | -5.655 M | -1.567 M | -2.833 M | |
Ebit | -1.395 M | -1.611 M | -3.580 M | -631.025 K | -5.655 M | -1.565 M | -2.832 M | |
Pretax income | -1.729 M | -2.027 M | -4.165 M | -1.806 M | -6.161 M | -2.029 M | -3.263 M | |
17.21% | 105.49% | -56.64% | 241.14% | -67.07% | 60.83% | |||
Income tax | 9.596 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net income | -1.739 M | -2.027 M | -4.165 M | -1.806 M | -6.161 M | -2.029 M | -3.263 M | |
-16.56% | -105.49% | 56.64% | -241.14% | 67.07% | -60.83% |